CNBC · General

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

· By Annika Kim Constantino
Story summary

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Read at CNBC

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.